- Home
- DYAI vs OMIC Comparison
DYAI vs OMIC Comparison
Compare DYAI & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYAI
- OMIC
- Stock Information
- Founded
- DYAI 1979
- OMIC 2016
- Country
- DYAI United States
- OMIC United States
- Employees
- DYAI N/A
- OMIC N/A
- Industry
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- OMIC Medical/Dental Instruments
- Sector
- DYAI Health Care
- OMIC Health Care
- Exchange
- DYAI Nasdaq
- OMIC Nasdaq
- Market Cap
- DYAI 31.5M
- OMIC 34.9M
- IPO Year
- DYAI 2004
- OMIC 2021
- Fundamental
- Price
- DYAI $1.47
- OMIC $19.60
- Analyst Decision
- DYAI Strong Buy
- OMIC Hold
- Analyst Count
- DYAI 1
- OMIC 2
- Target Price
- DYAI $6.00
- OMIC $10.75
- AVG Volume (30 Days)
- DYAI 91.0K
- OMIC 11.4K
- Earning Date
- DYAI 11-12-2024
- OMIC 11-12-2024
- Dividend Yield
- DYAI N/A
- OMIC N/A
- EPS Growth
- DYAI N/A
- OMIC N/A
- EPS
- DYAI N/A
- OMIC N/A
- Revenue
- DYAI $3,364,548.00
- OMIC $2,667,000.00
- Revenue This Year
- DYAI $51.30
- OMIC $3.98
- Revenue Next Year
- DYAI $73.26
- OMIC $242.05
- P/E Ratio
- DYAI N/A
- OMIC N/A
- Revenue Growth
- DYAI 13.82
- OMIC 2.77
- 52 Week Low
- DYAI $0.93
- OMIC $5.34
- 52 Week High
- DYAI $2.67
- OMIC $23.41
- Technical
- Relative Strength Index (RSI)
- DYAI 44.84
- OMIC 45.59
- Support Level
- DYAI $1.47
- OMIC $19.01
- Resistance Level
- DYAI $1.70
- OMIC $21.90
- Average True Range (ATR)
- DYAI 0.16
- OMIC 0.86
- MACD
- DYAI -0.05
- OMIC -0.34
- Stochastic Oscillator
- DYAI 3.70
- OMIC 21.81
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.